Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| R01AR069114 | Treg Migration and Function During Autoimmunity within Peripheral Tissue | 1 | 2020 |
| R01AR071522 | Fine mapping rheumatic disease variants using functional genomic sequencing | 1 | 2020 |
| R01CA056821 | Immunization Against Melanoma Differentiation Antigens | 1 | 2020 |
| R01CA129769 | Older Breast Cancer Patients: Risk For Cognitive Decline | 1 | 2020 |
| R01CA193473 | Integrative systems approach to identify local oncogenic modulation of the IL12 axis | 1 | 2020 |
| R01CA197936 | Determinants of acquired resistance in small cell lung cancer | 1 | 2020 |
| R01CA200703 | Genetic Epidemiology of non-Hodgkin Lymphoma | 1 | 2020 |
| R01CA202929 | Role of CX3CR1 in breast cancer metastasis | 1 | 2020 |
| R01CA204419 | Induction of Therapeutic Immunity in the Tumor Microenvironment | 1 | 2020 |
| R01CA204797 | Biological implications of breast cancer protective variants in Latin Americanwomen with high Indigenous American ancestry | 1 | 2020 |
| R01CA205239 | TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY | 1 | 2020 |
| R01CA205954 | (PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS) | 1 | 2020 |
| R01CA207377 | Adaptive resistance to HIF1a inhibition in hypoxia | 1 | 2020 |
| R01CA208303 | Developing a targeted chemoprevention strategy for Non-Small Cell Lung Cancer | 1 | 2020 |
| R01DC005805 | Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis | 1 | 2020 |
| R01DK106593 | Integrative Genomic Analyses of Macrophages in Crohns Disease | 1 | 2020 |
| R01DK116731 | Discovery and validation of biomarkers of cardiovascular complications in type 1 diabetes | 1 | 2020 |
| R01ES025534 | Interactions between antigen-specific effector and regulatory T cells in beryllium-induced disease | 1 | 2020 |
| R01EY002858 | Development of Visual Connections | 1 | 2020 |
| R01FD006589 | Scaffolds mimicking antigen presenting cells | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=40